FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| Park Avenue Compounding | 83863-0329 | 83863-0329-1 | Neostigmine Methylsulfate 5 mg in 5 mL (1mg/mL) | Neostigmine Methylsulfate 5 mg in 5 mL (1mg/mL) | 1 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| SSM Health Businesses dba Park Avenue Compounding | 119151370 | 83863-0329 | 83863-0329-1 | Neostigmine Methylsulfate | 1 mg/1 mL | 2025-2 | valid | 2026-10-06 | |
| Park Avenue Compounding | 83863-0329 | 83863-0329-1 | Neostigmine Methylsulfate 5 mg in 5 mL (1mg/mL) | Neostigmine Methylsulfate 5 mg in 5 mL (1mg/mL) | 1 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| SSM Health Businesses dba Park Avenue Compounding | 119151370 | 83863-0329 | 83863-0329-1 | Neostigmine Methylsulfate | 1 mg/1 mL | 2025-1 | valid | 2026-10-06 | |
| Park Avenue Compounding | 83863-0329 | 83863-0329-1 | Neostigmine Methylsulfate 5 mg in 5 mL (1mg/mL) | Neostigmine Methylsulfate 5 mg in 5 mL (1mg/mL) | 1 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| SSM Health Businesses dba Park Avenue Compounding | 119151370 | 83863-0329 | 83863-0329-1 | Neostigmine Methylsulfate | 1 mg/1 mL | 2024-2 | valid | 2026-10-06 | |
| SSM Health Businesses dba Park Avenue Compounding | 119151370 | 83863-0329 | 83863-0329-1 | Neostigmine Methylsulfate | 1 mg/1 mL | 2024-2 | valid | 2026-10-06 |